Symbols / BGM Stock $0.33 +0.00% BGM Group Ltd.

Healthcare • Drug Manufacturers - Specialty & Generic • China • NCM
BGM (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
CEO Mr. Chen Xin
Exch · Country NCM · China
Market Cap 67.01M
Enterprise Value 21.46M
Income —
Sales —
FCF (ttm) —
Book/sh 1.85
Cash/sh 0.15
Employees —
Insider 10d —
IPO Jan 12, 2021
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 0.00%
P/E —
Forward P/E —
PEG —
P/S —
P/B 0.18
P/C —
EV/EBITDA —
EV/Sales —
Quick Ratio —
Current Ratio —
Debt/Eq 0.97
LT Debt/Eq —
EPS (ttm) -0.29
EPS next Y —
EPS Growth —
Revenue Growth 13.90%
EPS Gr Q/Q —
Rev Gr Q/Q —
Earnings (next) 2026-03-16
Earnings (prior) 2026-03-16
ROA —
ROE —
ROIC —
Gross Margin 0.00%
Oper. Margin -15.64%
Profit Margin 0.00%
Shs Outstand 180.62M
Shs Float —
Insider Own 63.68%
Instit Own 0.17%
Short Float 0.04%
Short Ratio 0.07
Short Interest 40.25K
52W High 17.17
vs 52W High -98.05%
52W Low 0.27
vs 52W Low 22.79%
Beta —
Impl. Vol. —
Rel Volume 0.02
Avg Volume 265.52K
Volume 5.40K
Target (mean) —
Tgt Median —
Tgt Low —
Tgt High —
# Analysts —
Recom None
Prev Close $0.33
Price $0.33
Change 0.00%
About

BGM Group Ltd., through its subsidiaries, operates as a pharmaceutical and chemical company in China. It offers oxytetracycline products, including Qilian Shan oxytetracycline tablets to prevent and treat a range of diseases in chickens, turkeys, cattle, swine, and human; and Qilian Shan oxytetracycline active pharmaceutical ingredients, which are used by pharmaceutical companies in the manufacturing of medications that use oxytetracycline as an active ingredient. The company also provides licorice products, such as Gan Di Xin, a medicine made from raw licorice materials; Qilian Shan licorice extract, an ingredient for pharmaceutical companies to manufacture traditional licorice tablets; and Qilian Shan licorice liquid extract, an ingredient for medical preparation companies to produce compound licorice oral solutions. In addition, it offers traditional Chinese medicine derivatives products comprising Ahan antibacterial paste that is used to treat refractory chronic skin diseases; heparin products, including heparin sodium preparation, an ingredient for pharmaceutical companies to produce medications used in treating cardiovascular diseases, cerebrovascular diseases, and hemodialysis; and sausage casings, such as Zhu Xiaochang sausage casings for culinary purposes. Further, the company provides Fertilizer products comprising Xiongguan organic fertilizers to improve crop yield, increase soil's chemical properties, and reduce soil compaction; and Xiongguan organic-inorganic compound fertilizers for plant growth. Additionally, it focuses on the AI-driven commercialization of DuXiaoBao platform. BGM Group Ltd. is based in Chengdu, China.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
—
Mean price target
2. Current target
$0.33
Latest analyst target
3. DCF / Fair value
—
Simplified FCF or EPS-based estimate
Ratings
Current target
$0.33
Low
—
High
—
Mean
—
News
RSS: Latest BGM news
Insider Transactions

No recent insider transactions.

Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2024-09-30 2023-09-30 2022-09-30 2021-09-30
Total Revenue
25.10
-45.99%
46.47
-28.35%
64.86
+13.58%
57.10
Operating Revenue
25.10
-45.99%
46.47
-28.35%
64.86
+13.58%
57.10
Cost Of Revenue
20.98
-53.08%
44.72
-23.72%
58.63
+13.93%
51.46
Reconciled Cost Of Revenue
20.98
-53.08%
44.72
-23.72%
58.63
+13.93%
51.46
Gross Profit
4.11
+134.93%
1.75
-71.87%
6.23
+10.44%
5.64
Operating Expense
4.47
+7.26%
4.17
+12.33%
3.71
+38.16%
2.69
Research And Development
1.36
+139.50%
0.57
-53.57%
1.22
—
Selling General And Administration
3.32
-12.55%
3.79
+30.75%
2.90
-10.75%
3.25
Selling And Marketing Expense
0.59
-38.35%
0.96
+27.98%
0.75
—
General And Administrative Expense
2.72
-3.79%
2.83
+31.72%
2.15
—
Other Gand A
2.72
-3.79%
2.83
+31.72%
2.15
—
Other Operating Expenses
-0.21
-7.30%
-0.19
+53.50%
-0.41
+26.66%
-0.56
Total Expenses
25.46
-47.93%
48.89
-21.58%
62.34
+15.13%
54.15
Operating Income
-0.36
+85.22%
-2.42
-196.10%
2.52
-14.78%
2.95
Total Operating Income As Reported
-0.56
+78.40%
-2.61
-224.17%
2.10
-11.98%
2.39
EBITDA
0.88
+169.03%
-1.27
-134.08%
3.74
-9.94%
4.15
Normalized EBITDA
1.80
-57.62%
4.25
-6.69%
4.55
+23.35%
3.69
Reconciled Depreciation
1.24
+8.24%
1.14
-6.66%
1.22
+1.95%
1.20
EBIT
-0.36
+85.22%
-2.42
-196.10%
2.52
-14.78%
2.95
Total Unusual Items
-0.92
+83.33%
-5.52
-579.54%
-0.81
-275.93%
0.46
Total Unusual Items Excluding Goodwill
-0.92
+83.33%
-5.52
-579.54%
-0.81
-275.93%
0.46
Net Income
-1.44
+81.46%
-7.78
-822.64%
1.08
-65.85%
3.15
Pretax Income
-2.14
+72.96%
-7.90
-606.41%
1.56
-53.60%
3.36
Net Non Operating Interest Income Expense
-0.64
-744.73%
0.10
+298.99%
0.02
+143.11%
-0.06
Interest Expense Non Operating
—
—
—
0.06
Net Interest Income
-0.64
-744.73%
0.10
+298.99%
0.02
+143.11%
-0.06
Interest Expense
—
—
—
0.06
Interest Income Non Operating
—
—
0.02
—
Interest Income
—
—
0.02
—
Other Income Expense
-1.14
+79.58%
-5.58
-469.82%
-0.98
-309.05%
0.47
Other Non Operating Income Expenses
-0.01
+75.67%
-0.06
+63.52%
-0.17
-2562.33%
0.01
Gain On Sale Of Security
-0.92
+83.33%
-5.52
-579.54%
-0.81
-275.93%
0.46
Tax Provision
-0.62
-382.88%
0.22
+12.80%
0.19
-23.84%
0.26
Tax Rate For Calcs
0.00
+16.04%
0.00
+100.00%
0.00
+64.47%
0.00
Tax Effect Of Unusual Items
-0.27
+80.66%
-1.38
-1259.09%
-0.10
-389.35%
0.04
Net Income Including Noncontrolling Interests
-1.52
+81.32%
-8.12
-694.48%
1.37
-56.04%
3.11
Net Income From Continuing Operation Net Minority Interest
-1.44
+81.46%
-7.78
-822.64%
1.08
-65.85%
3.15
Net Income From Continuing And Discontinued Operation
-1.44
+81.46%
-7.78
-822.64%
1.08
-65.85%
3.15
Net Income Continuous Operations
-1.52
+81.32%
-8.12
-694.48%
1.37
-56.04%
3.11
Minority Interests
0.07
-78.23%
0.34
+217.92%
-0.29
-747.45%
0.04
Normalized Income
-0.79
+78.31%
-3.64
-303.48%
1.79
-34.41%
2.73
Net Income Common Stockholders
-1.44
+81.46%
-7.78
-822.64%
1.08
-65.85%
3.15
Diluted EPS
-0.20
+81.48%
-1.08
-820.00%
0.15
-66.67%
0.45
Basic EPS
-0.20
+81.48%
-1.08
-820.00%
0.15
-66.67%
0.45
Basic Average Shares
7.23
+0.00%
7.23
+0.00%
7.23
+5.99%
6.82
Diluted Average Shares
7.23
+0.00%
7.23
+0.00%
7.23
+5.99%
6.82
Diluted NI Availto Com Stockholders
-1.44
+81.46%
-7.78
-822.64%
1.08
-65.85%
3.15
Earnings From Equity Interest
-0.20
0.00
0.00
—
Total Other Finance Cost
0.64
+744.73%
-0.10
-298.99%
-0.02
-143.11%
0.06
Line Item Trend 2024-09-30 2023-09-30 2022-09-30 2021-09-30
Total Assets
53.00
+3.41%
51.26
-20.56%
64.53
-14.37%
75.35
Current Assets
29.77
-13.74%
34.51
+14.91%
30.03
-25.59%
40.37
Cash Cash Equivalents And Short Term Investments
18.14
-19.08%
22.42
+56.57%
14.32
+36.80%
10.47
Cash And Cash Equivalents
9.82
+31.31%
7.48
-47.79%
14.32
+36.80%
10.47
Other Short Term Investments
8.32
-44.30%
14.94
0.00
—
Receivables
5.77
-9.12%
6.35
+30.44%
4.87
-63.83%
13.47
Accounts Receivable
1.54
-21.89%
1.98
+142.32%
0.82
-52.96%
1.73
Gross Accounts Receivable
1.68
-15.28%
1.98
+141.74%
0.82
-57.87%
1.95
Allowance For Doubtful Accounts Receivable
-0.14
-2227.09%
-0.01
-33.30%
-0.00
+97.94%
-0.21
Other Receivables
0.19
-22.26%
0.25
-83.17%
1.47
+10336.10%
0.01
Taxes Receivable
0.70
0.00
—
—
Inventory
5.05
+1.17%
4.99
-43.79%
8.88
-28.94%
12.50
Raw Materials
2.33
-15.44%
2.75
-39.86%
4.58
-27.20%
6.29
Work In Process
0.40
+68.18%
0.24
-68.22%
0.75
-10.05%
0.83
Finished Goods
2.42
-16.25%
2.89
-29.21%
4.08
-25.89%
5.50
Prepaid Assets
0.80
+7.57%
0.75
-42.68%
1.30
-27.26%
1.79
Current Deferred Assets
—
—
—
0.00
Restricted Cash
—
0.00
-100.00%
0.66
-69.17%
2.14
Other Current Assets
—
—
-0.00
—
Total Non Current Assets
23.23
+38.75%
16.75
-51.45%
34.49
-1.42%
34.99
Net PPE
14.91
+17.36%
12.71
+3.36%
12.29
+7.06%
11.48
Gross PPE
39.02
+12.25%
34.77
+1.63%
34.21
-0.92%
34.53
Accumulated Depreciation
-24.11
-9.30%
-22.06
-0.65%
-21.92
+4.90%
-23.05
Properties
13.52
+4.88%
12.89
0.00
0.00
Buildings And Improvements
13.52
+4.40%
12.95
+8.50%
11.93
+21.41%
9.83
Machinery Furniture Equipment
19.20
+4.85%
18.31
-3.88%
19.05
-6.75%
20.43
Construction In Progress
6.30
+79.91%
3.50
+8.76%
3.22
-24.48%
4.26
Other Properties
—
0.06
—
—
Goodwill And Other Intangible Assets
4.54
+32.59%
3.42
+98.25%
1.73
-10.43%
1.93
Other Intangible Assets
4.54
+32.59%
3.42
+98.25%
1.73
-10.43%
1.93
Investments And Advances
3.36
+454.42%
0.61
-96.98%
20.09
-4.17%
20.96
Long Term Equity Investment
3.36
+454.42%
0.61
-1.87%
0.62
-3.42%
0.64
Non Current Deferred Assets
0.42
+3838.34%
0.01
-94.94%
0.21
-50.16%
0.43
Non Current Deferred Taxes Assets
0.42
+3838.34%
0.01
-94.94%
0.21
-50.16%
0.43
Other Non Current Assets
—
—
0.17
-8.47%
0.19
Total Liabilities Net Minority Interest
8.91
+29.01%
6.91
-27.78%
9.56
-48.82%
18.68
Current Liabilities
8.78
+31.77%
6.66
-27.45%
9.18
-49.49%
18.17
Payables And Accrued Expenses
8.21
+64.09%
5.00
-26.52%
6.81
-8.22%
7.42
Payables
7.29
+92.10%
3.80
-37.82%
6.11
-12.14%
6.95
Accounts Payable
4.13
+14.83%
3.59
-32.08%
5.29
-20.38%
6.64
Current Accrued Expenses
0.92
-24.10%
1.21
+71.91%
0.70
+50.22%
0.47
Total Tax Payable
0.32
+54.95%
0.20
-75.06%
0.82
+167.21%
0.31
Income Tax Payable
0.00
-99.09%
0.13
-10.10%
0.14
-4.01%
0.15
Current Debt And Capital Lease Obligation
—
0.55
-67.38%
1.70
-78.59%
7.92
Current Debt
—
0.48
-71.31%
1.67
-78.74%
7.87
Current Capital Lease Obligation
0.00
-100.00%
0.07
+208.31%
0.02
-57.28%
0.06
Current Deferred Liabilities
0.57
-48.56%
1.11
+63.01%
0.68
-76.10%
2.84
Current Deferred Revenue
0.57
-48.56%
1.11
+63.01%
0.68
-76.10%
2.84
Total Non Current Liabilities Net Minority Interest
0.13
-45.47%
0.25
-35.56%
0.38
-24.99%
0.51
Long Term Debt And Capital Lease Obligation
0.00
-100.00%
0.02
-66.12%
0.07
-31.68%
0.11
Long Term Capital Lease Obligation
0.00
-100.00%
0.02
-66.12%
0.07
-31.68%
0.11
Non Current Deferred Liabilities
0.13
-39.43%
0.22
-28.41%
0.31
-23.23%
0.40
Non Current Deferred Revenue
0.13
-39.43%
0.22
-28.41%
0.31
-23.23%
0.40
Stockholders Equity
42.74
-0.11%
42.79
-19.34%
53.05
-3.29%
54.86
Common Stock Equity
42.74
-0.11%
42.79
-19.34%
53.05
-3.29%
54.86
Capital Stock
0.06
+0.00%
0.06
+0.00%
0.06
+0.00%
0.06
Common Stock
0.06
+0.00%
0.06
+0.00%
0.06
+0.00%
0.06
Share Issued
7.23
+1.07%
7.15
+0.00%
7.15
+0.00%
7.15
Ordinary Shares Number
7.23
+1.07%
7.15
+0.00%
7.15
+0.00%
7.15
Additional Paid In Capital
36.41
+0.00%
36.41
+0.00%
36.41
+0.05%
36.39
Retained Earnings
4.35
-26.24%
5.90
-61.98%
15.51
+5.55%
14.69
Gains Losses Not Affecting Retained Earnings
1.92
+352.43%
0.43
-60.35%
1.07
-71.13%
3.71
Minority Interest
1.35
-13.45%
1.56
-18.42%
1.91
+5.61%
1.81
Other Equity Adjustments
1.92
+352.43%
0.43
-60.35%
1.07
-71.13%
3.71
Total Equity Gross Minority Interest
44.09
-0.58%
44.35
-19.31%
54.96
-3.01%
56.67
Total Capitalization
42.74
-0.11%
42.79
-19.34%
53.05
-3.29%
54.86
Working Capital
20.99
-24.63%
27.85
+33.56%
20.85
-6.02%
22.19
Invested Capital
42.74
-1.22%
43.27
-20.93%
54.72
-12.76%
62.73
Total Debt
0.00
-100.00%
0.58
-67.33%
1.77
-77.97%
8.03
Capital Lease Obligations
0.00
-100.00%
0.10
+1.80%
0.10
-40.51%
0.16
Net Tangible Assets
38.20
-2.96%
39.37
-23.30%
51.33
-3.03%
52.93
Tangible Book Value
38.20
-2.96%
39.37
-23.30%
51.33
-3.03%
52.93
Available For Sale Securities
—
—
19.47
-4.20%
20.32
Current Notes Payable
—
0.00
-100.00%
1.53
-80.53%
7.87
Dueto Related Parties Current
2.85
0.00
—
—
Inventories Adjustments Allowances
-0.10
+89.19%
-0.89
-69.20%
-0.52
-318.28%
-0.13
Investmentin Financial Assets
—
0.00
-100.00%
19.47
-4.20%
20.32
Line Of Credit
0.00
-100.00%
0.48
+241.24%
0.14
0.00
Notes Receivable
3.34
-19.22%
4.13
+59.77%
2.59
-77.94%
11.72
Line Item Trend 2024-09-30 2023-09-30 2022-09-30 2021-09-30
Operating Cash Flow
0.54
+74.32%
0.31
-97.53%
12.65
+3567.52%
0.35
Cash Flow From Continuing Operating Activities
0.54
+74.32%
0.31
-97.53%
12.65
+3567.52%
0.35
Net Income From Continuing Operations
-1.52
+81.32%
-8.12
-694.48%
1.37
-56.04%
3.11
Depreciation Amortization Depletion
1.24
+8.24%
1.14
-6.66%
1.22
+1.95%
1.20
Depreciation
1.14
+5.38%
1.08
-8.12%
1.17
-7.20%
1.26
Amortization Cash Flow
0.10
+55.05%
0.07
+26.26%
0.05
—
Depreciation And Amortization
1.24
+8.24%
1.14
-6.66%
1.22
+1.95%
1.20
Amortization Of Intangibles
0.10
+55.05%
0.07
+26.26%
0.05
—
Other Non Cash Items
0.06
+133.95%
0.03
+15.73%
0.02
-64.03%
0.06
Stock Based Compensation
0.00
0.00
-100.00%
0.02
0.00
Provisionand Write Offof Assets
-0.74
-273.99%
0.43
+65.12%
0.26
+206.72%
0.08
Deferred Tax
-0.41
-299.88%
0.20
+7.22%
0.19
+511.02%
-0.05
Deferred Income Tax
-0.41
-299.88%
0.20
+7.22%
0.19
+511.02%
-0.05
Operating Gains Losses
0.31
+7732.67%
-0.00
+87.23%
-0.03
+54.76%
-0.07
Gain Loss On Investment Securities
0.10
+2623.75%
-0.00
+90.01%
-0.04
+42.16%
-0.07
Unrealized Gain Loss On Investment Securities
0.82
-85.18%
5.53
+547.99%
0.85
+363.76%
-0.32
Change In Working Capital
0.79
-29.36%
1.11
-87.29%
8.75
+338.34%
-3.67
Change In Receivables
1.33
+145.97%
-2.89
-129.56%
9.77
+6304.68%
-0.16
Changes In Account Receivables
0.38
+130.94%
-1.22
-219.01%
1.03
+288.50%
-0.55
Change In Inventory
0.96
-71.84%
3.40
+52.59%
2.23
+4666.40%
0.05
Change In Prepaid Assets
-0.07
-113.28%
0.49
+1077.14%
0.04
+104.89%
-0.86
Change In Payables And Accrued Expense
0.84
+149.68%
-1.69
-2202.60%
0.08
+429.79%
-0.02
Change In Accrued Expense
0.36
-33.46%
0.54
+79.23%
0.30
+133.56%
-0.90
Change In Payable
0.48
+121.56%
-2.23
-910.46%
-0.22
-125.28%
0.87
Change In Account Payable
0.38
+123.42%
-1.62
-100.92%
-0.81
-139.96%
2.02
Change In Other Working Capital
-0.67
-277.57%
0.38
+117.75%
-2.12
-28.75%
-1.65
Change In Other Current Assets
-1.51
-206.52%
1.41
+217.99%
-1.20
-17.41%
-1.02
Change In Other Current Liabilities
-0.10
-2443.16%
0.00
+107.80%
-0.06
-325.15%
-0.01
Investing Cash Flow
0.98
+120.74%
-4.74
-45.52%
-3.26
+86.53%
-24.20
Cash Flow From Continuing Investing Activities
0.98
+120.74%
-4.74
-45.52%
-3.26
+86.53%
-24.20
Net PPE Purchase And Sale
-2.85
-54.34%
-1.85
+42.81%
-3.23
+7.43%
-3.49
Purchase Of PPE
-2.85
-54.34%
-1.85
+42.81%
-3.23
+7.43%
-3.49
Capital Expenditure
-3.93
-5.85%
-3.71
-13.97%
-3.26
+6.71%
-3.49
Net Investment Purchase And Sale
4.86
+585.87%
-1.00
0.00
+100.00%
-20.00
Purchase Of Investment
-1.40
-40.49%
-1.00
0.00
+100.00%
-20.00
Sale Of Investment
6.26
0.00
0.00
0.00
Net Business Purchase And Sale
0.00
+100.00%
-0.03
0.00
+100.00%
-0.71
Purchase Of Business
0.00
+100.00%
-0.03
0.00
+100.00%
-0.71
Net Intangibles Purchase And Sale
-1.08
+42.20%
-1.87
-6890.99%
-0.03
-1374.20%
-0.00
Purchase Of Intangibles
-1.08
+42.20%
-1.87
-6890.99%
-0.03
-1374.20%
-0.00
Net Other Investing Changes
—
—
-0.00
—
Financing Cash Flow
-0.49
+83.17%
-2.92
+50.80%
-5.94
-124.75%
23.99
Cash Flow From Continuing Financing Activities
-0.49
+83.17%
-2.92
+50.80%
-5.94
-124.75%
23.99
Net Issuance Payments Of Debt
-0.49
+58.69%
-1.19
+79.95%
-5.94
-4900.06%
0.12
Issuance Of Debt
0.00
-100.00%
0.50
-84.52%
3.20
-58.94%
7.80
Repayment Of Debt
-0.49
+70.84%
-1.69
+81.55%
-9.14
-19.02%
-7.68
Long Term Debt Issuance
—
—
3.20
-58.94%
7.80
Long Term Debt Payments
—
—
-6.09
+20.71%
-7.68
Net Long Term Debt Issuance
—
—
-2.89
-136.97%
7.80
Short Term Debt Issuance
0.00
-100.00%
0.50
-84.52%
3.20
0.00
Short Term Debt Payments
-0.49
+70.84%
-1.69
+81.55%
-9.14
-19.02%
-7.68
Net Short Term Debt Issuance
-0.49
+58.69%
-1.19
+79.95%
-5.94
+22.70%
-7.68
Net Common Stock Issuance
—
0.00
0.00
-100.00%
23.87
Common Stock Dividend Paid
—
-1.79
0.00
—
Cash Dividends Paid
0.00
+100.00%
-1.79
0.00
—
Net Other Financing Charges
—
0.06
—
—
Changes In Cash
1.04
+114.09%
-7.35
-312.61%
3.46
+2399.43%
0.14
Effect Of Exchange Rate Changes
1.31
+961.75%
-0.15
+86.06%
-1.09
-280.44%
0.60
Beginning Cash Position
7.48
-50.09%
14.98
+18.81%
12.61
+6.24%
11.87
End Cash Position
9.82
+31.31%
7.48
-50.09%
14.98
+18.81%
12.61
Free Cash Flow
-3.39
+0.43%
-3.40
-136.21%
9.40
+398.42%
-3.15
Interest Paid Supplemental Data
0.00
+16.58%
0.00
-97.01%
0.12
-19.84%
0.15
Income Tax Paid Supplemental Data
0.02
-20.15%
0.03
0.00
-100.00%
0.82
Change In Income Tax Payable
0.10
+116.63%
-0.61
-204.72%
0.58
+151.17%
-1.14
Change In Tax Payable
0.10
+116.63%
-0.61
-204.72%
0.58
+151.17%
-1.14
Common Stock Issuance
—
0.00
0.00
-100.00%
23.87
Dividends Received CFI
0.06
0.00
0.00
—
Earnings Losses From Equity Investments
0.20
0.00
0.00
—
Issuance Of Capital Stock
—
0.00
0.00
-100.00%
23.87
SEC Filings

No SEC filings found for this symbol (may be non-US or ticker not in SEC index).

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category